Search filters

List of works by Smruthi Vijayaraghavan

AXL Inhibition Suppresses the DNA Damage Response and Sensitizes Cells to PARP Inhibition in Multiple Cancers.

scientific article published on 26 September 2016

Amivantamab (JNJ-61186372), An Fc Enhanced EGFR/cMet Bispecific Antibody Induces Receptor Downmodulation And Anti-tumor Activity By Monocyte/Macrophage Trogocytosis

scientific article published on 03 August 2020

CDK4/6 and autophagy inhibitors synergistically induce senescence in Rb positive cytoplasmic cyclin E negative cancers.

scientific article

CDK4/6 inhibitors sensitize Rb-positive sarcoma cells to Wee1 kinase inhibition through reversible cell cycle arrest.

scientific article published on 15 June 2017

Combined Inhibition of STAT3 and DNA Repair in Palbociclib-Resistant ER-Positive Breast Cancer

scientific article published on 13 March 2019

Cyclin E Overexpression Sensitizes Triple-Negative Breast Cancer to Wee1 Kinase Inhibition

scientific article published on 04 September 2018

Inhibiting CDK in Cancer Therapy: Current Evidence and Future Directions.

scientific article published on 7 December 2017

Molecular genetics and cellular events of K-Ras-driven tumorigenesis.

scientific article published on 23 October 2017

Sequential Combination Therapy of CDK Inhibition and Doxorubicin Is Synthetically Lethal in p53-Mutant Triple-Negative Breast Cancer

scientific article published on 29 January 2016

Synthetic lethality of PARP inhibitors in combination with MYC blockade is independent of BRCA status in triple negative breast cancer

scientific article published on 27 November 2017

Paulina is supported by:

About Paulina

Help